Latest News & Features
Americas
Pharmaceutical company Merck has bought Afferent Pharmaceuticals in a deal worth $500 million. 10 June 2016
Americas
In today’s video interview LSIPR speaks to Dr Ruhong Jiang, president of biotechnology company Applied StemCell, about its work with the CRISPR/Cas9 technology. 9 June 2016
Americas
A US court has overturned an earlier ruling in which Merck was awarded $200 million in damages for patent infringement after finding that the pharmaceutical company had engaged in misconduct. 9 June 2016
Americas
A day after Hillary Clinton won in California and five months ahead of the US general election, the 2016 BIO International Convention hosted a Keynote session to hear the thoughts of political experts. 9 June 2016
Americas
This year’s BIO International Convention took a turn for the groovy on Wednesday night, with a 'Summer of Love' party at San Francisco City Hall. 9 June 2016
Asia-Pacific
Sequenom has filed a patent infringement lawsuit against Sonic Healthcare, Australian Clinical Labs and Ariosa Diagnostics at the Australian Federal Court. 8 June 2016
Biotechnology
Lawyers are navigating an “uncertain terrain” when presiding over cases involving biosimilars, a speaker at the 2016 BIO International Convention has said. 8 June 2016
Americas
Gender diversity was the topic of our next video interview where we discovered that the biotechnology industry is an "old boys network". 8 June 2016
Americas
Casey Thampoe, managing IP counsel for biologics and vaccines at Merck & Co, speaks to LSIPR. 8 June 2016
Americas
Hollywood actor Will Smith has praised the power of science and the work of neuropathologist Dr Bennet Omalu during a speech at the 2016 BIO International Convention. 8 June 2016